Syphilis TP Rapid Test Kits in Dominican Republic: Protecting Mothers and Babies from Congenital Syphilis

The Dominican Republic carries one of the highest syphilis burdens in the Caribbean. Despite being entirely preventable with penicillin treatment, syphilis – and in particular congenital syphilis (syphilis transmitted from mother to baby during pregnancy) – continues to cause devastating outcomes including stillbirth, neonatal death, and lifelong disability. PAHO and

WHO have identified the elimination of congenital syphilis as a regional priority, and the cornerstone of this effort is universal antenatal syphilis screening using rapid test kits. The Syphilis TP Rapid Test Kit from Jal Medical’s iCARE range is the tool that can make this vision a reality in the Dominican Republic.

Need More Information?
WhatsApp Email Us Today!

Congenital Syphilis: A Preventable Tragedy

Congenital syphilis occurs when a pregnant woman with untreated syphilis transmits the infection to her foetus through the placenta. The consequences are catastrophic: Up to 40% of pregnancies affected by untreated syphilis result in stillbirth or neonatal death Surviving infants may suffer blindness, deafness, bone deformities, neurological damage, and organ failure All of these outcomes are entirely preventable with a syphilis test and penicillin treatment costing just a few dollars In the Dominican Republic, despite high antenatal care attendance rates, gaps in syphilis screening – particularly among women who receive care late in pregnancy, access care through informal midwifery, or live in rural or border areas – mean that congenital syphilis cases continue to occur. The answer is expanding syphilis rapid testing to every point of maternal contact.

iCARE Syphilis TP Rapid Test: Clinical Performance and Formats

iCARE LH Ovulation Rapid Test Kits

The iCARE Syphilis TP Rapid Test detects antibodies to Treponema pallidum (the bacterium that causes syphilis) using the TP antigen – making it a treponemal test that detects both current and past syphilis infection. Available in multiple formats: Syphilis IgM/IgG Field Test Kit – detects both IgM (indicating recent/active infection) and IgG (indicating past exposure or ongoing infection) – Jal Medical’s #1 ranked product for Syphilis IgM/IgG Field Test Kit

Syphilis IgM Field Test Kit – for recent/active infection focus

Syphilis IgG Field Test Kit – for general syphilis exposure screening Syphilis TP Rapid Screen Test – standard cassette format for clinic use Syphilis Home Test Kit / Syphilis self test kit – for private home-based screening

Key specifications:

Blood sample (fingerprick, venous, or serum/plasma)

Result in 10-15 minutes

No laboratory required

High sensitivity (>99%) and specificity

Suitable for clinic, antenatal, field, and home settings

WHO PQ Listed – iCARE Syphilis Anti-TP Rapid Test Card carries WHO Prequalification

The WHO PQ LISTED SYPHILIS ANTI-TP RAPID TEST CARD and WHO PQ LISTED SYPHILIS RAPID TEST CARD status of the iCARE product make it eligible for PAHO and UNICEF procurement – directly relevant to the Dominican Republic’s maternal health programmes.

Deployment Strategy for Dominican Republic

Antenatal clinics and maternity hospitals: Integration of the syphilis rapid test into first trimester antenatal visits in Santo Domingo, Santiago, La Romana, San Pedro de Macoris, and rural health posts ensures maximum coverage. PAHO recommends testing at every antenatal contact for women in high-prevalence settings – the syphilis rapid test kit makes this achievable at the point of care.

Labour and delivery: Women presenting in labour without prior antenatal care – a key risk group for congenital syphilis – should be tested immediately using the rapid test. The 15-minute result time enables same-visit treatment before delivery.

NGO and community health: Border communities with Haiti, sex worker populations, and other high-risk groups can be reached through mobile and community health programmes using the syphilis home test kit and syphilis self test kit.

Speak with an Expert
WhatsApp Call Us Now!

For Health Buyers and Distributors

As a leading syphilis rapid test kit manufacturer, syphilis test kit supplier, and syphilis kits manufacturer, Jal Medical supplies to government health ministries, PAHO procurement, international NGOs, and commercial distributors across the Caribbean. The iCARE syphilis range is available in bulk formats with WHO PQ documentation for public health procurement compliance.

Every case of congenital syphilis in the Dominican Republic is a preventable tragedy. The Syphilis TP Rapid Test Kit from Jal Medical provides the fast, accurate, affordable maternal screening tool that can protect babies from this outcome. Contact Jal Medical today for bulk supply, WHO PQ documentation, and distributor partnership for the Dominican Republic and Caribbean region.

About Author:

JAL Medical Singapore
Mr. Andre Han

Managing Director, JAL Medical Singapore

Mr. Andre Han is the Managing Director of JAL Medical Singapore, a strategic subsidiary of a publicly listed biomedical manufacturer headquartered in Hsinchu, Taiwan. The parent company is internationally recognized for its ISO 13485 and GMP-certified production capabilities, delivering high-quality diagnostic solutions to global healthcare markets.
With over 20 years of experience in the medical device industry, Mr. Han brings deep expertise in commercial strategy, product development, and international market expansion. He oversees a comprehensive portfolio that includes in-vitro diagnostic test kits including STD Rapid Test Kits, HCG Pregnancy Test Kit, HIV Test Kit, Ovulation Detection Kit, Dengue Test Kits, Syphilis Test Kits, Herpes Test Kit, Chlamydia Rapid Test Kit, Gonorrhoea Test Kit, Menopause Test Kit, and proprietary blood glucose monitoring systems tailored for both clinical and home environments. Under Mr. Han’s leadership, JAL Medical has:

  • Distributed hundreds of millions of rapid diagnostic test kits globally
  • Secured long-term national tenders in South Africa
  • Expanded into key markets including Laos, Mongolia, Ghana, Kenya, Ukraine, Nigeria, and Japan
Beyond commercial operations, Mr. Han spearheads consultancy initiatives focused on:
  • Rapid test innovation and development
  • Facility optimization and regulatory alignment
  • Enhancing quality, reliability, and affordability across product lines
His strategic vision and commitment to innovation continue to position JAL Medical Singapore as a trusted provider of accessible, high-performance healthcare technologies worldwide.